Adaptive Biotechnologies CEO on partnership with Microsoft to study Covid-19
The race is on for improved testing, treatment and a vaccine for Covid-19. One company is partnering with Microsoft to decode how the human immune system responds to the virus. Chad Robins, Adaptive Biotechnologies CEO and co-founder, joins "Squawk Box" to discuss ways to make testing more reliable.
Wed, May 6 20208:54 AM EDT